221 related articles for article (PubMed ID: 18303632)
1. [Analysis on direct economic burden of community COPD patients and its influence factors in Chengdu].
Zhang B; Zhang Y; Yang J; Liu X
Wei Sheng Yan Jiu; 2007 Nov; 36(6):706-10. PubMed ID: 18303632
[TBL] [Abstract][Full Text] [Related]
2. [Analysis on direct economic burden of stroke in the rural population of Hanzhong, Shaanxi Province].
Long Y; Lu J; Xu DZ; Hu JX; Jiang JH; Yan YP; Huang JY; Yang J
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Jul; 26(7):494-7. PubMed ID: 16334999
[TBL] [Abstract][Full Text] [Related]
3. [Factors influencing the use of health care services from patients with COPD in Chengdu].
Zhang B; Zhang Y; Liu HC; Tian J; Tu GP
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Mar; 38(2):316-20. PubMed ID: 17441359
[TBL] [Abstract][Full Text] [Related]
4. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
[TBL] [Abstract][Full Text] [Related]
5. [Impact of chronic obstructive pulmonary disease on quality of life and economic burden in Chinese urban areas].
He QY; Zhou X; Xie CM; Liang ZA; Chen P; Wu CG
Zhonghua Jie He He Hu Xi Za Zhi; 2009 Apr; 32(4):253-7. PubMed ID: 19576036
[TBL] [Abstract][Full Text] [Related]
6. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
[TBL] [Abstract][Full Text] [Related]
7. The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population.
Menzin J; Boulanger L; Marton J; Guadagno L; Dastani H; Dirani R; Phillips A; Shah H
Respir Med; 2008 Sep; 102(9):1248-56. PubMed ID: 18620852
[TBL] [Abstract][Full Text] [Related]
8. [Financial burden of hepatitis B-related diseases and factors influencing the costs in Shenzhen, China].
Liang S; Zhang SX; Ma QS; Xiao HW; Lü QY; Xie X; Mei SJ; Hu DS; Zhou BP; Li B; Chen JF; Cui FQ; Wang FZ; Liang XF
Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1340-5. PubMed ID: 21223660
[TBL] [Abstract][Full Text] [Related]
9. Economic burden prior to COPD diagnosis: a matched case-control study in the United States.
Akazawa M; Halpern R; Riedel AA; Stanford RH; Dalal A; Blanchette CM
Respir Med; 2008 Dec; 102(12):1744-52. PubMed ID: 18760581
[TBL] [Abstract][Full Text] [Related]
10. Economic burden of chronic obstructive pulmonary disease.
Teo WS; Tan WS; Chong WF; Abisheganaden J; Lew YJ; Lim TK; Heng BH
Respirology; 2012 Jan; 17(1):120-6. PubMed ID: 21954985
[TBL] [Abstract][Full Text] [Related]
11. Clinical and economic burden of patients diagnosed with COPD with comorbid cardiovascular disease.
Dalal AA; Shah M; Lunacsek O; Hanania NA
Respir Med; 2011 Oct; 105(10):1516-22. PubMed ID: 21684731
[TBL] [Abstract][Full Text] [Related]
12. [The analysis of drug cost and direct medical expense in community health management of hypertensive patients].
Liang XH; Gu DF; Zhang H; Zhu K; Deng Y; Cao J; Zhou ZY; Wang Y; Wan GS; Zhao C; Mu QC; Lu FH
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Aug; 45(8):732-6. PubMed ID: 22169696
[TBL] [Abstract][Full Text] [Related]
13. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen.
Rascati KL; Akazawa M; Johnsrud M; Stanford RH; Blanchette CM
Clin Ther; 2007 Jun; 29(6):1203-13. PubMed ID: 17692734
[TBL] [Abstract][Full Text] [Related]
14. Cost analysis of chronic obstructive pulmonary disease in a tertiary care setting in Taiwan.
Chiang CH
Respirology; 2008 Sep; 13(5):689-94. PubMed ID: 18513247
[TBL] [Abstract][Full Text] [Related]
15. Economic assessment of early initiation of inhaled corticosteroids in chronic obstructive pulmonary disease using propensity score matching.
Akazawa M; Biddle AK; Stearns SC
Clin Ther; 2008; 30 Spec No():1003-16. PubMed ID: 18640475
[TBL] [Abstract][Full Text] [Related]
16. [Study on direct economic-burden and its risk factors of osteoporotic hip fracture].
Luo LZ; Xu L
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Sep; 26(9):669-72. PubMed ID: 16471214
[TBL] [Abstract][Full Text] [Related]
17. [Community-based study on disease burden of diarrhea in Zhejiang province].
Chai CL; Lv HK; Yu Z; Qin SW; Wang XX; Chen K; Xie SY
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Oct; 30(10):1005-9. PubMed ID: 20193377
[TBL] [Abstract][Full Text] [Related]
18. Cost impact of COPD in Japan: opportunities and challenges?
Nishimura S; Zaher C
Respirology; 2004 Nov; 9(4):466-73. PubMed ID: 15612957
[TBL] [Abstract][Full Text] [Related]
19. Costs of chronic obstructive pulmonary disease (COPD) in Italy: the SIRIO study (social impact of respiratory integrated outcomes).
Dal Negro RW; Tognella S; Tosatto R; Dionisi M; Turco P; Donner CF
Respir Med; 2008 Jan; 102(1):92-101. PubMed ID: 17881206
[TBL] [Abstract][Full Text] [Related]
20. Economic implications of comorbid conditions among Medicaid beneficiaries with COPD.
Lin PJ; Shaya FT; Scharf SM
Respir Med; 2010 May; 104(5):697-704. PubMed ID: 19954941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
